Study finds higher risk of rare blood cancer after chemo - NCI

Study finds higher risk of rare blood cancer after chemo - NCI

5
(568)
Write Review
More
$ 25.99
Add to Cart
In stock
Description

An NIH study finds patients treated with chemotherapy for most solid tumors had an increased risk of tMDS/AML, a rare but often fatal type of leukemia.

Researchers find lorlatinib to be safe and effective treatment for

Life, Free Full-Text

Study: Cancer research identifies fungi in 35 types of cancer

The More You Know About Cancer Prevention

Childhood Hodgkin Lymphoma Treatment (PDQ®)–Patient Version

Cancers, Free Full-Text

Car-T Therapy May Increase Risk of Certain Cancers

An emerging trend of rapid increase of leukemia but not all

Can a Blood Test Detect Cancer in the Body?

INTERNATIONAL STUDY FINDS NEW GENETIC FEATURES IN RARE BURKITT

Cancer Risk By Age: What the Science Says

Cancers, Free Full-Text

Novel treatment shows promise against rare cancer in kids - Los